Promises and Challenges of Targeting Inflammation to Treat Cardiovascular Disease: the Post-CANTOS Era
Overview
Affiliations
Deng X, Deng Q, Zhang Q, Hou J Front Cardiovasc Med. 2025; 12:1419314.
PMID: 39901898 PMC: 11788360. DOI: 10.3389/fcvm.2025.1419314.
Targeting Inflammatory Pathways in Atherosclerosis: Exploring New Opportunities for Treatment.
DAiello A, Filomia S, Brecciaroli M, Sanna T, Pedicino D, Liuzzo G Curr Atheroscler Rep. 2024; 26(12):707-719.
PMID: 39404934 PMC: 11530513. DOI: 10.1007/s11883-024-01241-3.
Los J, Mensink F, Mohammadnia N, Opstal T, Damman P, Volleberg R Front Cardiovasc Med. 2024; 11:1352025.
PMID: 38370159 PMC: 10871865. DOI: 10.3389/fcvm.2024.1352025.
Tang J, Li T, Xiong X, Yang Q, Su Z, Zheng M J Nanobiotechnology. 2023; 21(1):460.
PMID: 38037046 PMC: 10690998. DOI: 10.1186/s12951-023-02228-z.
A Novel Monocyte Subset as a Unique Signature of Atherosclerotic Plaque Rupture.
Vinci R, Pedicino D, Bonanni A, DAiello A, Severino A, Pisano E Front Cell Dev Biol. 2021; 9:753223.
PMID: 34712669 PMC: 8545820. DOI: 10.3389/fcell.2021.753223.